Procedures requiring radiographic contrast are increasingly being used to assist in diagnosis. However there is an associated risk of inducing nephropathy. Different regimens have been reported to prevent or reduce this complication. The most popular of these involves using the free radical scavenger, N-acetylcysteine, as it has been postulated that contrast-induced nephropathy is mediated by the formation of free radicals promoted by an acidic environment. An alternative strategy, adopted by these authors, is the use of bicarbonate to alkalinise renal tubular fluid to reduce nephrotoxicity.
Design
This was a prospective, single-centre randomised controlled trial, without intention to treat, conducted over a ten-month period. One hundred and nineteen patients with stable creatinine levels were enrolled in the study. Entry criteria included age >18yrs, a stable serum creatinine >97.2 micromol/l and the need to undergo a procedure requiring contrast injection (mainly cardiac catheterisation and computerised tomography (CT)). Exclusion criteria included serum creatinine >707 micromol/l, a change in creatinine > 44.2 micromol/l in the 24 hrs preceding the procedure, pre-existing dialysis, pregnancy, certain medical conditions and drugs, and an allergy to, or recent use of, radiocontrast material.
Patients were randomised to receive either 154mEq/L sodium bicarbonate or 154mEq/L sodium chloride before and after administration of non-ionic contrast. This was administered as a bolus of 3mls/kg per hour over 1hr pre-contrast, followed by an infusion of 1ml/kg per hour for 6 hours after the procedure. Serum creatinine levels were measured at baseline and one and two days after contrast. Contrast induced nephropathy was defined as an increase of 25% or more in serum creatinine within 48hrs of contrast.
Results
Contrast induced nephropathy occurred in 8 patients (13.6%) in the sodium chloride group and 1 patient (1.7%) in the sodium bicarbonate group.
Conclusion
The authors conclude that if radiocontrast material is to be given for a procedure, hydration with sodium bicarbonate is more efficacious than sodium chloride in reducing renal failure.
Are the Results of the study valid Primary Guides
Assignment of patients to each treatment group was kept concealed and was achieved by a computer-generated randomisation schedule. Nine patients from each group were excluded from the study on the basis of incomplete laboratory results or protocol violations, mainly additional drug therapy. All other patients were accounted for on conclusion of the study.
Secondary Guides
An attempt was made to keep patients and clinicians 'blinded' to treatment assignment but this was not achieved completely, as investigators could have determined the treatment group by inspection of solutions infused. The two groups were treated equally.
At the start of the trial there was no statistically significant difference between the groups as far as clinical and biochemical characteristics, although in terms of baseline serum creatinine and glomerular filtration rate, randomisation was slightly biased against patients receiving sodium bicarbonate.
Are the Valid Results of this trial important?
The outcome measure of contrast induced nephropathy was expressed an increase in serum creatinine >25% from baseline, within 48hrs. 
Prevention of Contrast-Induced Nephropathy with Sodium Bicarbonate
Prevention of Contrast-Induced Nephropathy with Sodium Bicarbonate development of clinically significant renal failure requiring renal replacement therapy has yet to be proven. Additionally, the volume and nature of contrast material used impacts on the incidence of nephropathy. In the majority of critical care patients contrast is administered during CT scanning and angiography rather than cardiac catheterisation.
Nevertheless this study appears to show a reduction in the incidence of contrast-induced nephropathy using sodium bicarbonate instead of sodium chloride. The mechanism by which this benefit arises can also be accounted for in terms of urinary pH, with a significant alkalinisation of the urine occurring after an initial bolus of sodium bicarbonate. Differences between the treatments were evident from changes in the serum creatinine (increased in the sodium chloride group and decreased in the sodium bicarbonate group) and the estimated glomerular filtration rate (decreased in the sodium chloride group and increased in the sodium bicarbonate group).
Conclusion
The use of sodium bicarbonate to reduce the risk of contrast-induced nephropathy appears to be simple and safe. As it has been shown to offer a potential advantage over sodium chloride in prophylaxis of contrast-induced nephropathy, it should be considered as the peri-procedural hydration fluid of choice.
